首页> 美国卫生研究院文献>Journal of Veterinary Internal Medicine >Cardiorenal and endocrine effects of synthetic canine BNP1‐32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease

【2h】

Cardiorenal and endocrine effects of synthetic canine BNP1‐32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease

机译：犬类二尖瓣疾病引起的充血性心力衰竭的犬的合成犬BNP1-32的心肾和内分泌作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe effects of synthetic brain natriuretic peptide (BNP1‐32) on cardiorenal and renin angiotensin aldosterone system in dogs with naturally occurring congestive heart failure (CHF) are unknown.

机译：背景合成脑利钠肽（BNP1-32）对自然充血性心力衰竭（CHF）犬心肾和肾素血管紧张素醛固酮系统的影响尚不清楚。

著录项

期刊名称 Journal of Veterinary Internal Medicine
作者
Mariko Yata; Hans S. Kooistra; Niek J. Beijerink;
展开▼
作者单位

展开▼
年(卷),期 2019(33),2
年度 2019
页码 462–470
总页数 9
原文格式 PDF
正文语种
中图分类动物医学（兽医学）;
关键词
aldosterone brain natriuretic peptide canine cGMP RAAS;

机译：醛固酮;脑钠肽;犬;cGMP;RAAS;

相似文献

外文文献
中文文献
专利

1. Cardiorenal and endocrine effects of synthetic canine BNP1‐32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease [J] . Mariko Yata, Hans S. Kooistra, Niek J. Beijerink Journal of Veterinary Internal Medicine . 2019,第2期

机译：犬类二尖瓣疾病引起的充血性心力衰竭的犬的合成犬BNP1-32的心肾和内分泌作用
2. Left atrial decompression as a palliative minimally invasive treatment for congestive heart failure caused by myxomatous mitral valve disease in dogs: 17 cases (2018-2019) [J] . Allen Justin W., Phipps Kevin L., Llamas Anthony A., Journal of the American Veterinary Medical Association . 2021,第6期

机译：左心房减压作为犬瘤中近螨二尖瓣病引起的充血性心力衰竭的姑息性微创治疗：17例（2018-2019）
3. Effect of Pimobendan or Benazepril Hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. [J] . Haggstrom J., Boswood A., OGrady M., Kleintier-Praxis: Archiv fur Kleine Haus- und Nutztiere Sowie Laboratoriums- und Zoo-Tiere . 2008,第12期

机译：QUEST研究显示，匹莫苯或盐酸贝那普利对自然发生的粘液性二尖瓣疾病所致充血性心力衰竭犬的存活时间的影响。
4. PREDICTING FIRST ONSET OF CONGESTIVE HEART FAILURE IN DOGS WITH MITRAL VALVE DISEASE [C] . Mark A. Oyama American College of Veterinary Internal Medicine Forum . 2012

机译：二尖瓣病的狗犬充血性心力衰竭的首次发作
5. Valve interstitial cell phenotypes and signaling pathways involved with canine myxomatous degenerative mitral valve disease. [D] . Disatian, Sirilak. 2008

机译：犬粘液变性变性二尖瓣疾病所涉及的瓣膜间质细胞表型和信号通路。
6. Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST) [O] . Melissa Coffman, Emilie Guillot, Thomas Blondel, 2021

机译：肌瘤二尖瓣病引起的犬脑血糖和螺旋酮组合的临床疗效：苯甲酸纤维素肺内酯研究（BESST）
7. Left atrial decompression as a palliative minimally invasive treatment for congestive heart failure caused by myxomatous mitral valve disease in dogs: 17 cases (2018–2019) [O] . Justin W. Allen, Kevin L. Phipps, Anthony A. Llamas, 2021

机译：左心房减压作为犬杀菌二尖瓣病引起的充血性心力衰竭的姑息性微创治疗：17例（2018-2019）

Cardiorenal and endocrine effects of synthetic canine BNP1‐32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease

摘要

著录项

相似文献

相关主题

期刊订阅